Gillian A M Tarr1, Xiao-Li Pang2, Ran Zhuo3, Bonita E Lee4, Linda Chui2, Samina Ali5, Otto G Vanderkooi6, Christine Michaels-Igbokwe7, Phillip I Tarr8, Shannon E MacDonald9, Gillian Currie7, Judy MacDonald10, Kelly Kim11, Stephen B Freedman12. 1. Division of Environmental Health Sciences, University of Minnesota, Minneapolis, Minnesota, USA. 2. Department of Laboratory Medicine and Pathology, University of Alberta and Alberta Precision Laboratories-ProvLab, Edmonton, Alberta, Canada. 3. Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada. 4. Department of Pediatrics, Women and Children's Health Research Institute, University of Alberta, Edmonton, Alberta, Canada. 5. Departments of Pediatrics and Emergency Medicine, Women and Children's Health Research Institute, University of Alberta, Edmonton, Alberta, Canada. 6. Departments of Pediatrics, Microbiology, Immunology and Infectious Diseases, Pathology and Laboratory Medicine, and Community Health Sciences, Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada. 7. Departments of Pediatrics and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada. 8. Division of Gastroenterology, Hepatology, & Nutrition, Washington University School of Medicine, St Louis, Missouri, USA. 9. Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada. 10. Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. 11. Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada. 12. Sections of Pediatric Emergency Medicine and Gastroenterology, Department of Pediatrics, Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Abstract
BACKGROUND: Norovirus is a leading cause of acute gastroenteritis. With vaccines in development, population-based estimates of norovirus burden are needed to identify target populations, quantify potential benefits, and understand disease dynamics. METHODS: We estimated the attributable fraction (AF) for norovirus infections in children, defined as the proportion of children testing positive for norovirus whose gastroenteritis was attributable to norovirus. We calculated the standardized incidence and emergency department (ED) visit rates attributable to norovirus using provincial gastroenteritis visit administrative data. RESULTS: From 3731 gastroenteritis case patients and 2135 controls we determined that the AFs were 67.0% (95% confidence interval [CI], 31.5%-100%) and 91.6% (88.8%-94.4%) for norovirus genogroups I (GI) and II (GII), respectively. Norovirus GII AF varied by season but not age. We attributed 116 episodes (95% CI, 103-129) and 59 (51-67) ED visits per 10 000 child-years to norovirus GII across all ages, accounting for 20% and 18% of all medically attended gastroenteritis episodes and ED visits, respectively. CONCLUSIONS: In children, a large proportion of norovirus GII detections reflect causation, demonstrating significant potential for norovirus GII vaccines. Seasonal variation in the norovirus GII AF may have implications for understanding the role asymptomatic carriage plays in disease dynamics.
BACKGROUND:Norovirus is a leading cause of acute gastroenteritis. With vaccines in development, population-based estimates of norovirus burden are needed to identify target populations, quantify potential benefits, and understand disease dynamics. METHODS: We estimated the attributable fraction (AF) for norovirusinfections in children, defined as the proportion of children testing positive for norovirus whose gastroenteritis was attributable to norovirus. We calculated the standardized incidence and emergency department (ED) visit rates attributable to norovirus using provincial gastroenteritis visit administrative data. RESULTS: From 3731 gastroenteritis case patients and 2135 controls we determined that the AFs were 67.0% (95% confidence interval [CI], 31.5%-100%) and 91.6% (88.8%-94.4%) for norovirus genogroups I (GI) and II (GII), respectively. Norovirus GIIAF varied by season but not age. We attributed 116 episodes (95% CI, 103-129) and 59 (51-67) ED visits per 10 000 child-years to norovirus GII across all ages, accounting for 20% and 18% of all medically attended gastroenteritis episodes and ED visits, respectively. CONCLUSIONS: In children, a large proportion of norovirus GII detections reflect causation, demonstrating significant potential for norovirus GII vaccines. Seasonal variation in the norovirus GIIAF may have implications for understanding the role asymptomatic carriage plays in disease dynamics.
Authors: Stephen B Freedman; Jianling Xie; Alberto Nettel-Aguirre; Bonita Lee; Linda Chui; Xiao-Li Pang; Ran Zhuo; Brendon Parsons; James A Dickinson; Otto G Vanderkooi; Samina Ali; Lara Osterreicher; Karen Lowerison; Phillip I Tarr Journal: Lancet Gastroenterol Hepatol Date: 2017-07-14
Authors: James A Platts-Mills; Sudhir Babji; Ladaporn Bodhidatta; Jean Gratz; Rashidul Haque; Alexandre Havt; Benjamin Jj McCormick; Monica McGrath; Maribel Paredes Olortegui; Amidou Samie; Sadia Shakoor; Dinesh Mondal; Ila Fn Lima; Dinesh Hariraju; Bishnu B Rayamajhi; Shahida Qureshi; Furqan Kabir; Pablo P Yori; Brenda Mufamadi; Caroline Amour; J Daniel Carreon; Stephanie A Richard; Dennis Lang; Pascal Bessong; Esto Mduma; Tahmeed Ahmed; Aldo Aam Lima; Carl J Mason; Anita Km Zaidi; Zulfiqar A Bhutta; Margaret Kosek; Richard L Guerrant; Michael Gottlieb; Mark Miller; Gagandeep Kang; Eric R Houpt Journal: Lancet Glob Health Date: 2015-07-19 Impact factor: 26.763
Authors: P F M Teunis; F H A Sukhrie; H Vennema; J Bogerman; M F C Beersma; M P G Koopmans Journal: Epidemiol Infect Date: 2014-10-22 Impact factor: 4.434
Authors: Stephen B Freedman; Bonita E Lee; Marie Louie; Xiao-Li Pang; Samina Ali; Andy Chuck; Linda Chui; Gillian R Currie; James Dickinson; Steven J Drews; Mohamed Eltorki; Tim Graham; Xi Jiang; David W Johnson; James Kellner; Martin Lavoie; Judy MacDonald; Shannon MacDonald; Lawrence W Svenson; James Talbot; Phillip Tarr; Raymond Tellier; Otto G Vanderkooi Journal: BMC Pediatr Date: 2015-07-31 Impact factor: 2.125
Authors: Mayuko Saito; Sonia Goel-Apaza; Susan Espetia; Daniel Velasquez; Lilia Cabrera; Sebastian Loli; Jean E Crabtree; Robert E Black; Margaret Kosek; William Checkley; Mirko Zimic; Caryn Bern; Vitaliano Cama; Robert H Gilman Journal: Clin Infect Dis Date: 2013-12-02 Impact factor: 9.079
Authors: Scott P Grytdal; Emilio DeBess; Lore E Lee; David Blythe; Patricia Ryan; Christianne Biggs; Miriam Cameron; Mark Schmidt; Umesh D Parashar; Aron J Hall Journal: PLoS One Date: 2016-04-26 Impact factor: 3.240
Authors: Mark R Zweigart; Sylvia Becker-Dreps; Filemón Bucardo; Fredman González; Ralph S Baric; Lisa C Lindesmith Journal: Viruses Date: 2021-10-09 Impact factor: 5.048